Gastric Cancer: D2 Dissection or Low Maruyama Index-Based Surgery-a Debate

Surgical Oncology Clinics of North America

Volumn 16, Issue 1, 2007, Pages 133-155

  Douglass Jr , Harold O ^a,b   Hundahl, Scott A ^c,d   Macdonald, John S ^e,f   Khatri, Vijay P ^g  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^e ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^f Aptium Oncology   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURGERY; LYMPH NODE METASTASIS; REVIEW; STOMACH CANCER; SURVIVAL RATE;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33847407470     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2006.10.005     Document Type: Review

References (78)

1. Baxter N.N., and Tuttle T.M. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 12 12 (2005) 981-987
2. Wanebo H.J., Kennedy B.J., Winchester D.P., et al. Gastric carcinoma: does lymph node dissection alter survival?. J Am Coll Surg 183 6 (1996) 616-624
3. Hundahl S.A., Macdonald J.S., Benedetti J., et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 9 3 (2002) 278-286
4. Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol 21 23 Suppl (2003) 274s-275s
5. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group. Cancer 49 6 (1982) 1116-1122
6. Hallissey M.T., Dunn J.A., Ward L.C., et al. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343 8909 (1994) 1309-1312
7. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79 9-10 (1999) 1522-1530
8. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 10 (2001) 725-730
9. Bozzetti F., Bonfanti G., Bufalino R., et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 196 6 (1982) 685-690
10. Gunderson L.L., and Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8 1 (1982) 1-11
11. Schwarz R.E. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116. J Clin Oncol 19 6 (2001) 1879-1880
12. Kodama Y., Sugimachi K., Soejima K., et al. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 5 2 (1981) 241-248
13. Koga S., Kaibara N., Nishidoi H., et al. Lymph node removal for advanced gastric cancer with special reference to peritoneal metastasis. Zentralbl Chir 108 21 (1983) 1377-1381
14. Smith D.D., Schwarz R.R., and Schwarz R.E. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23 28 (2005) 7114-7124
15. Jatzko G.R., Lisborg P.H., Denk H., et al. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 76 8 (1995) 1302-1312
16. Volpe C.M., Koo J., Miloro S.M., et al. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg 181 1 (1995) 56-64
17. Collard J.M., Malaise J., Mabrut J.Y., et al. Skeletonizing en-bloc gastrectomy for adenocarcinoma in caucasian patients. Gastric Cancer 6 4 (2003) 210-216
18. Sierra A., Regueira F.M., Hernandez-Lizoain J.L., et al. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10 3 (2003) 219-226
19. Roviello F., Marrelli D., Morgagni P., et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 9 9 (2002) 894-900
20. Jaehne J., Meyer H.J., Maschek H., et al. Lymphadenectomy in gastric carcinoma: a prospective and prognostic study. Arch Surg 127 3 (1992) 290-294
21. Shiu M.H., Moore E., Sanders M., et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma: a retrospective multivariate analysis. Arch Surg 122 11 (1987) 1347-1351
22. Hartgrink H.H., van de Velde C.J., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22 11 (2004) 2069-2077
23. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 347 9007 (1996) 995-999
24. Kim J.P., Kwon O.J., Oh S.T., et al. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 216 3 (1992) 269-278 [discussion: 278-9]
25. Japanese Research Society for Gastric Cancer. The general rules for the Gastric Cancer Study in Surgery and Pathology. Part I. Jpn J Surg 11 (1981) 127-139
26. Douglass H.O.J. Gastric cancer. In: Ritchie Jr. W.P., and Steele G. (Eds). General surgery. 1st edition (1995), J.B. Lippincott Co, Philadelphia 133-164
27. Bonenkamp J.J., Hermans J., Sasako M., et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340 12 (1999) 908-914
28. Kodera Y., Schwarz R.E., and Nakao A. Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials?. J Am Coll Surg 195 6 (2002) 855-864
29. Khatri V.P., and Douglass H.O.J. D2.5 dissection for gastric carcinoma. Arch Surg 139 6 (2004) 662-669
30. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1 1 (1998) 10-24
31. Aiko T., and Sasako M. The new Japanese classification of gastric carcinoma: points to be revised. Gastric Cancer 1 1 (1998) 25-30
32. Doglietto G.B., Pacelli F., Caprino P., et al. Pancreas-preserving total gastrectomy for gastric cancer. Arch Surg 135 1 (2000) 89-94
33. Kodera Y., Sasako M., Yamamoto S., et al. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 92 9 (2005) 1103-1109
34. Furukawa H., Hiratsuka M., Ishikawa O., et al. Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method. Ann Surg Oncol 7 9 (2000) 669-673
35. Papachristou D., and Fortner J.G. Biliary obstruction after gastrectomy for carcinoma of the stomach. Surg Gynecol Obstet 147 3 (1978) 401-404
36. Stomach cancer. In: Green F, editor. AJCC cancer staging manual. 6th edition. New York: Springer-Verlag; 2002. p. 99-106.
37. Nitti D., Marchet A., Olivieri M., et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10 9 (2003) 1077-1085
38. Takagane A., Terashima M., Abe K., et al. Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer 2 2 (1999) 122-128
39. Kinoshita T., Maruyama K., Sasako M., et al. [Lymph node dissection around the splenic artery for gastric cancer-a comparative study of pancreatectomy and pancreas-preserving operation]. Nippon Geka Gakkai Zasshi 93 2 (1992) 128-132
40. Maruyama K., Sasako M., Kinoshita T., et al. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 19 4 (1995) 532-536
41. Ono H., Kondo H., Gotoda T., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48 2 (2001) 225-229
42. Hiki Y. [Endoscopic mucosal resection (EMR) for early gastric cancer]. Nippon Geka Gakkai Zasshi 97 4 (1996) 273-278
43. Sasako M. Treatment of early gastric cancer. Chir Ital 49 3 (1997) 9-13
44. Yamao T., Shirao K., Ono H., et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 77 4 (1996) 602-606
45. Kurita A., Takashima S., Doihara H., et al. [Limited surgery for early gastric cancer]. Nippon Geka Gakkai Zasshi 94 12 (1993) 1239-1243
46. Yoshino K., Matsui H., Aizawa K., et al. [Modified operation for an early stage gastric cancer]. Gan To Kagaku Ryoho 18 6 (1991) 939-944
47. Furukawa H., Hiratsuka M., Imaoka S., et al. Limited surgery for early gastric cancer in cardia. Ann Surg Oncol 5 4 (1998) 338-341
48. Maruyama K., Sasako M., Kinoshita T., et al. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol 23 3 (1996) 360-368
49. Gunderson L.L., and Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 34 4 (1974) 1278-1292
50. Katai H., Maruyama K., Sasako M., et al. Mode of recurrence after gastric cancer surgery. Dig Surg 11 (1994) 99-103
51. Hartgrink H.H., and van de Velde C.J. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol 90 3 (2005) 153-165
52. Macdonald J.S. Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 90 3 (2005) 166-170
53. Hundahl SA, Macdonald JS, Benedetti J. Durable survival impact of "Low Maruyama Index Surgery" in a trial of adjuvant chemoradiation for gastric cancer. Presented at the 2004 ASCO GI Symposium. San Francisco, 2004 January 22, 2004. Report No.: 48.
54. Dent D.M. Radical surgery for curable gastric carcinoma. S Afr Med J 84 2 (1994) 56-57
55. Gouzi J.L., Huguier M., Fagniez P.L., et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann Surg 209 2 (1989) 162-166
56. Bozzetti F., Marubini E., Bonfanti G., et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230 2 (1999) 170-178
57. Robertson C.S., Chung S.C., Woods S.D., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220 2 (1994) 176-182
58. Sasako M., Sano T., Yamamoto S., et al. Randomized phase III trial of standard D2 versus D2+ paraaortic node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG9501. J Clin Oncol 24 18-S, Pt II of II (2006) 934s
59. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7 4 (2006) 309-315
60. Roggin K.K., and Posner M.C. D3 or not D3: that is not the question. Lancet Oncol 7 4 (2006) 279-280
61. Bonenkamp J.J., Songun I., Hermans J., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 8952 (1995) 745-748
62. Japanese classification of gastric carcinoma, first English edition (1995), Kanehara& Co., LTD, Tokyo
63. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 11 2 (1981) 127-139
64. The general rules for gastric cancer study in surgery. Jpn J Surg 3 1 (1973) 61-71
65. Bunt A.M., Hermans J., Boon M.C., et al. Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol 12 2 (1994) 417-422
66. Brennan M.F. Lymph-node dissection for gastric cancer. N Engl J Med 340 12 (1999) 956-958
67. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 84 11 (1997) 1567-1571
68. Kampschoer G.H., Maruyama K., van de Velde C.J., et al. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 76 9 (1989) 905-908
69. Bollschweiler E., Boettcher K., Hoelscher A.H., et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg 79 2 (1992) 156-160
70. Guadagni S., de Manzoni G., Catarci M., et al. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer. World J Surg 24 12 (2000) 1550-1558
71. Siewert J.R., Kelsen D., Maruyama K., et al. Gastric cancer diagnosis and treatment-an interactive training program (2000), Spinger Electronic Media, Berlin
72. Peeters K.C.M.J., Hundahl S.A., Kranenbarg E.K., et al. "Low-Maruyama-Index" surgery for gastric cancer-a blinded re-analysis of the Dutch D1-D2 trial. World J Surg 29 (2005) 1576-1584
73. Inoue K., Nakane Y., Iiyama H., et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9 1 (2002) 27-34
74. Coburn NG, Swallow C, Quan ML, et-al. Significant regional variation in treatment and survival of gastric cancer. J Clin Oncol (Meeting Abstracts) 2005;23(16 Suppl):4004.
75. Petrelli N.J. The debate is over; it's time to move on. J Clin Oncol 22 11 (2004) 2041-2042
76. Macdonald JS, Smalley S, Benedetti J, et al. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction: update of the results of Intergroup study INT-0116 (SWOG 9008). Presented at the American Society of Clinical Oncology. New Orleans, LA, June 5-8, 2004.
77. Kim S., Lim do H., Lee J., et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63 5 (2005) 1279-1285
78. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy in operable gastric and lower esophageal cancer: final results of a randomized, controlled trial (The MAGIC trial, ISRCTN 93793971). Presented at the American Society of Clinical Oncology. Orlando, FL, May 13-17, 2005.